Tempest Therapeutics (TPST) Exchange Rate Effect (2018 - 2021)
Tempest Therapeutics (TPST) posted Exchange Rate Effect of -$6000.0 for Q1 2021, down 102.71% sequentially from $221000.0 in Q4 2020, and up 83.78% YoY from -$3264.7 in Q1 2020.
Tempest Therapeutics (TPST) Exchange Rate Effect (2018 - 2021) Analysis & Trends
Tempest Therapeutics has reported Exchange Rate Effect for 4 years, with the latest figure at -$6000.0 in Q1 2021.
- Quarterly Exchange Rate Effect rose 83.78% year-over-year to -$6000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $252000.0 (up 2420.0% YoY) and the FY2020 annual result came in at $221000.0, up 569.7% from the prior year.
- Exchange Rate Effect retreated to -$6000.0 in Q1 2021 per TPST's latest filing, from $221000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $221000.0 in Q4 2020 and troughed at -$48000.0 in Q3 2020.
- A 4-year average of $28153.8 and a median of -$6000.0 in 2021 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 689.29% in 2020, down 220.0% in 2020.
- Over 4 years, Exchange Rate Effect stood at $142000.0 in 2018, then tumbled by 80.28% to $28000.0 in 2019, then soared by 689.29% to $221000.0 in 2020, then slumped by 102.71% to -$6000.0 in 2021.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$6000.0, $221000.0, and -$48000.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Tempest Therapeutics | 4.23 Mn | 3.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -6,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Dec 31, 2020 | 221,000.00 |
| Dec 31, 2020 | 221,000.00 |
| Sep 30, 2020 | -48,000.00 |
| Sep 30, 2020 | -48,000.00 |
| Jun 30, 2020 | 85,000.00 |
| Jun 30, 2020 | 85,000.00 |
| Mar 31, 2020 | -37,000.00 |
| Mar 31, 2020 | -37,000.00 |
| Dec 31, 2019 | 28,000.00 |
| Dec 31, 2019 | 28,000.00 |
| Sep 30, 2019 | 40,000.00 |
| Sep 30, 2019 | 40,000.00 |
| Jun 30, 2019 | -21,000.00 |
| Jun 30, 2019 | -21,000.00 |
| Mar 31, 2019 | -14,000.00 |
| Mar 31, 2019 | -14,000.00 |
| Dec 31, 2018 | 142,000.00 |
| Dec 31, 2018 | 142,000.00 |